Compare ICFI & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICFI | ALVO |
|---|---|---|
| Founded | 1969 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2006 | N/A |
| Metric | ICFI | ALVO |
|---|---|---|
| Price | $97.22 | $4.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $99.25 | $9.25 |
| AVG Volume (30 Days) | 129.5K | ★ 550.5K |
| Earning Date | 02-26-2026 | 11-12-2025 |
| Dividend Yield | ★ 0.59% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.30 | 0.24 |
| Revenue | ★ $1,925,502,000.00 | $573,350,000.00 |
| Revenue This Year | N/A | $20.85 |
| Revenue Next Year | $2.52 | $44.49 |
| P/E Ratio | ★ $17.89 | $20.82 |
| Revenue Growth | N/A | ★ 45.55 |
| 52 Week Low | $72.03 | $4.32 |
| 52 Week High | $135.34 | $13.50 |
| Indicator | ICFI | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 72.68 | 47.21 |
| Support Level | $90.95 | $4.61 |
| Resistance Level | $94.99 | $5.01 |
| Average True Range (ATR) | 3.30 | 0.23 |
| MACD | 0.82 | 0.04 |
| Stochastic Oscillator | 95.40 | 56.43 |
ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.